S. Richard, B. Gardie, . Development-of-methodology:-s, C. Couv-e, S. Ladroue et al., Gardie Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc Gardie Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis, Mole, W. Kaelin, B. Gardie Writing, review, and/or revision of the manuscript: S. Couv e

P. R. Pag-es, B. Benusiglio, J. Bressac-de-paillerets, A. Feunteun, N. M. Gimenez-roqueplo et al., Gardie Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases, Gardie Other (performed laboratory techniques such as Western blot analysis, PCR, etc.): H. Le Jeune Other (provision of animals, acquisition and management of patients, provision of facilities, etc.): M. Le Gentil References

A. Berger, A. Knudson, and P. Pandolfi, A continuum model for tumour suppression, Nature, vol.129, issue.7359, pp.163-172, 2011.
DOI : 10.1038/nature10275
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206311

P. Maxwell, M. Wiesener, G. Chang, S. Clifford, E. Vaux et al., The tumour suppressor protein VHL targets hypoxiainducible factors for oxygen-dependent proteolysis, Nature, vol.399, pp.271-276, 1999.

C. Stebbins, W. Kaelin, . Jr, and N. Pavletich, Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function, Science, vol.284, issue.5413, pp.455-61, 1999.
DOI : 10.1126/science.284.5413.455

E. Maher, A. Webster, F. Richards, J. Green, P. Crossey et al., Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations., Journal of Medical Genetics, vol.33, issue.4, pp.328-360, 1996.
DOI : 10.1136/jmg.33.4.328

M. Nordstrom-o-'brien, R. Van-der-luijt, E. Van-rooijen, A. Van-den-ouweland, D. Majoor-krakauer et al., Genetic analysis of von Hippel-Lindau disease, Hum Mutat, vol.31, pp.521-558, 2010.

L. Li, L. Zhang, X. Zhang, Q. Yan, Y. Minamishima et al., Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations, Molecular and Cellular Biology, vol.27, issue.15, pp.5381-92, 2007.
DOI : 10.1128/MCB.00282-07
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1952077

M. Ohh, C. Park, M. Ivan, M. Hoffman, T. Kim et al., Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein, Nat Cell Biol, vol.2, pp.423-430, 2000.

J. Maranchie, A. Afonso, P. Albert, S. Kalyandrug, J. Phillips et al., Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location, Human Mutation, vol.91, issue.1, pp.40-46, 2004.
DOI : 10.1002/humu.10302

S. Ang, H. Chen, K. Hirota, V. Gordeuk, J. Jelinek et al., Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia, Nature Genetics, vol.59, issue.4, pp.614-635, 2002.
DOI : 10.1016/0167-4889(90)90126-X

W. Rathmell, M. Hickey, N. Bezman, C. Chmielecki, N. Carraway et al., In vitro and In vivo Models Analyzing von Hippel-Lindau Disease-Specific Mutations, Cancer Research, vol.64, issue.23, pp.8595-603, 2004.
DOI : 10.1158/0008-5472.CAN-04-1430

V. Gordeuk, A. Sergueeva, G. Miasnikova, D. Okhotin, Y. Voloshin et al., Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors, Blood, vol.103, issue.10, pp.3924-3956, 2004.
DOI : 10.1182/blood-2003-07-2535

C. Bento, M. Percy, B. Gardie, T. Maia, R. Van-wijk et al., Genetic Basis of Congenital Erythrocytosis: Mutation Update and Online Databases, Human Mutation, vol.367, issue.1, pp.15-26, 2014.
DOI : 10.1002/humu.22448

M. Hickey, J. Lam, N. Bezman, W. Rathmell, and M. Simon, von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis, J Clin Invest, vol.117, pp.3879-89, 2007.

K. Kapralova, L. Lanikova, F. Lorenzo, J. Song, M. Horvathova et al., RUNX1 and NF-E2 upregulation is not specific for MPNs, but is seen in polycythemic disorders with augmented HIF signaling, Blood, vol.123, issue.3, pp.391-395, 2014.
DOI : 10.1182/blood-2013-10-534222

J. Bond, D. Gale, T. Connor, S. Adams, J. De-boer et al., Dysregulation of the HIF pathway due to VHL mutation causing severe erythrocytosis and pulmonary arterial hypertension, Blood, vol.117, issue.13, pp.3699-701, 2011.
DOI : 10.1182/blood-2010-12-327569

S. Sarangi, L. Lanikova, K. Kapralova, S. Acharya, S. Swierczek et al., Cancer Research OF10 16 The homozygous VHL missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension, Cancer Res Pediatr Blood Cancer, vol.7461, issue.22, pp.2104-2110, 2014.
DOI : 10.1002/pbc.25056

H. Cario, K. Schwarz, N. Jorch, U. Kyank, P. Petrides et al., Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis, Haematologica, vol.90, pp.19-24, 2005.

E. Liu, M. Percy, C. Amos, Y. Guan, S. Shete et al., The worldwide distribution of the VHL 598C>T mutation indicates a single founding event, Blood, vol.103, issue.5, pp.1937-1977, 2004.
DOI : 10.1182/blood-2003-07-2550

E. Woodward, K. Wall, J. Forsyth, F. Macdonald, and E. Maher, VHL mutation analysis in patients with isolated central nervous system haemangioblastoma, Brain, vol.130, issue.3, pp.836-878, 2007.
DOI : 10.1093/brain/awl362
URL : http://doi.org/10.1093/brain/awl362

S. Olschwang, S. Richard, C. Boisson, S. Giraud, P. Laurent-puig et al., Germline mutation profile of the VHL gene in von Hippel???Lindau disease and in sporadic hemangioblastoma, Human Mutation, vol.12, issue.6, pp.424-454, 1998.
DOI : 10.1002/(SICI)1098-1004(1998)12:6<424::AID-HUMU9>3.3.CO;2-8

B. Zbar, T. Kishida, F. Chen, L. Schmidt, E. Maher et al., Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan, Human Mutation, vol.25, issue.4, pp.348-57, 1996.
DOI : 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3

J. Min, H. Yang, M. Ivan, F. Gertler, W. Kaelin et al., Structure of an HIF-1alpha -pVHL Complex: Hydroxyproline Recognition in Signaling, Science, vol.296, issue.5574, pp.1886-1895, 2002.
DOI : 10.1126/science.1073440

M. Kim, Y. Yan, K. Lee, M. Sgagias, and K. Cowan, Ectopic expression of von Hippel???Lindau tumor suppressor induces apoptosis in 786-O renal cell carcinoma cells and regresses tumor growth of 786-O cells in nude mouse, Biochemical and Biophysical Research Communications, vol.320, issue.3, pp.945-50, 2004.
DOI : 10.1016/j.bbrc.2004.06.042

D. Mole, C. Blancher, R. Copley, P. Pollard, J. Gleadle et al., Genome-wide Association of Hypoxia-inducible Factor (HIF)-1?? and HIF-2?? DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts, Journal of Biological Chemistry, vol.284, issue.25, pp.16767-75, 2009.
DOI : 10.1074/jbc.M901790200

G. Elvidge, L. Glenny, R. Appelhoff, P. Ratcliffe, J. Ragoussis et al., Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition: THE ROLE OF HIF-1??, HIF-2??, AND OTHER PATHWAYS, Journal of Biological Chemistry, vol.281, issue.22, pp.15215-15241, 2006.
DOI : 10.1074/jbc.M511408200

R. Beroukhim, J. Brunet, D. Napoli, A. Mertz, K. Seeley et al., Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney, Cancer Research, vol.69, issue.11, pp.4674-81, 2009.
DOI : 10.1158/0008-5472.CAN-09-0146

J. Liu and R. Nussinov, The Mechanism of Ubiquitination in the Cullin-RING E3 Ligase Machinery: Conformational Control of Substrate Orientation, PLoS Computational Biology, vol.215, issue.10, p.1000527, 2009.
DOI : 10.1371/journal.pcbi.1000527.s008

K. Kondo, W. Kim, M. Lechpammer, W. Kaelin, and . Jr, Inhibition of HIF2?? Is Sufficient to Suppress pVHL-Defective Tumor Growth, PLoS Biology, vol.146, issue.3, p.83, 2003.
DOI : 10.1371/journal.pbio.0000083.g004

J. Schodel, C. Bardella, L. Sciesielski, J. Brown, C. Pugh et al., Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression, Nature Genetics, vol.62, issue.4, pp.420-425, 2012.
DOI : 10.1101/gr.885403

P. Pollard, M. El-bahrawy, R. Poulsom, G. Elia, P. Killick et al., Mutations, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.11, pp.4593-4601, 2006.
DOI : 10.1210/jc.2006-0920
URL : https://hal.archives-ouvertes.fr/hal-00652407

Z. Zhuang, C. Yang, F. Lorenzo, M. Merino, T. Fojo et al., Gain-of-Function Mutations in Paraganglioma with Polycythemia, New England Journal of Medicine, vol.367, issue.10, pp.922-952, 2012.
DOI : 10.1056/NEJMoa1205119

V. Dondeti, B. Wubbenhorst, P. Lal, J. Gordan, D. Andrea et al., Integrative Genomic Analyses of Sporadic Clear Cell Renal Cell Carcinoma Define Disease Subtypes and Potential New Therapeutic Targets, Cancer Research, vol.72, issue.1, pp.112-133, 2012.
DOI : 10.1158/0008-5472.CAN-11-1698

A. Girgis, V. Iakovlev, B. Beheshti, J. Bayani, J. Squire et al., Multilevel Whole-Genome Analysis Reveals Candidate Biomarkers in Clear Cell Renal Cell Carcinoma, Cancer Research, vol.72, issue.20, pp.5273-84, 2012.
DOI : 10.1158/0008-5472.CAN-12-0656

L. Nikitenko, R. Leek, S. Henderson, N. Pillay, H. Turley et al., The G-Protein-Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis, Clinical Cancer Research, vol.19, issue.20, pp.5740-5748, 2013.
DOI : 10.1158/1078-0432.CCR-13-1712

S. Clifford, M. Cockman, A. Smallwood, D. Mole, E. Woodward et al., Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease, Human Molecular Genetics, vol.10, issue.10, pp.1029-1067, 2001.
DOI : 10.1093/hmg/10.10.1029

K. Hacker, C. Lee, and W. Rathmell, VHL Type 2B Mutations Retain VBC Complex Form and Function, PLoS ONE, vol.104, issue.11, p.3801, 2008.
DOI : 10.1371/journal.pone.0003801.g004
URL : http://doi.org/10.1371/journal.pone.0003801

M. Santarosa and A. Ashworth, Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1654, issue.2, pp.105-127, 2004.
DOI : 10.1016/j.bbcan.2004.01.001

R. Russell, R. Sufan, B. Zhou, P. Heir, S. Bunda et al., Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia, Nature Medicine, vol.90, issue.7, pp.845-53, 2011.
DOI : 10.1002/ajh.21381

A. Prowse, A. Webster, F. Richards, S. Richard, S. Olschwang et al., Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors, Am J Hum Genet, vol.60, pp.765-71, 1997.

S. Lee, E. Nakamura, H. Yang, W. Wei, M. Linggi et al., Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer, Cancer Cell, vol.8, issue.2, pp.155-67, 2005.
DOI : 10.1016/j.ccr.2005.06.015
URL : http://doi.org/10.1016/j.ccr.2005.06.015

H. Brauch, T. Kishida, D. Glavac, F. Chen, F. Pausch et al., Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect, Human Genetics, vol.95, issue.5, pp.551-557, 1995.
DOI : 10.1007/BF00223868

C. Gallou, D. Chauveau, S. Richard, D. Joly, S. Giraud et al., Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions, Human Mutation, vol.8, issue.1, pp.215-239, 2004.
DOI : 10.1002/humu.20082

M. Bento, K. Chang, Y. Guan, E. Liu, G. Caldas et al., Congenital polycythemia with homozygous and heterozygous mutations of von Hippel-Lindau gene: five new Caucasian patients, Haematologica, vol.90, pp.128-137, 2005.

S. Capodimonti, L. Teofili, M. Martini, T. Cenci, M. Iachininoto et al., von Hippel-Lindau Disease and Erythrocytosis, Journal of Clinical Oncology, vol.30, issue.13, pp.137-146, 2012.
DOI : 10.1200/JCO.2011.38.6797

F. Lorenzo, C. Yang, L. Lanikova, L. Butros, Z. Zhuang et al., T124A/L188V) associated with congenital polycythaemia, British Journal of Haematology, vol.98, issue.6, pp.851-854, 2013.
DOI : 10.1111/bjh.12431
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759558

Y. Pastore, K. Jedlickova, Y. Guan, E. Liu, J. Fahner et al., Mutations of von Hippel-Lindau Tumor-Suppressor Gene and Congenital Polycythemia, The American Journal of Human Genetics, vol.73, issue.2, pp.412-421, 2003.
DOI : 10.1086/377108

Y. Pastore, J. Jelinek, S. Ang, Y. Guan, E. Liu et al., Mutations in the VHL gene in sporadic apparently congenital polycythemia, Blood, vol.101, issue.4, pp.1591-1596, 2003.
DOI : 10.1182/blood-2002-06-1843

M. Ritter, A. Frilling, P. Crossey, W. Hoppner, E. Maher et al., Isolated familial pheochromocytoma as a variant of von Hippel- Lindau disease, J Clin Endocrinol Metab, vol.81, pp.1035-1042, 1996.

B. Gardie, M. Percy, D. Hoogewijs, R. Chowdhury, C. Bento et al., The role of PHD2 mutations in the pathogenesis of erythrocytosis, Hypoxia, vol.2, pp.71-90, 2014.
DOI : 10.2147/HP.S54455

C. Ladroue, R. Carcenac, M. Leporrier, S. Gad, L. Hello et al., Mutation and Congenital Erythrocytosis with Paraganglioma, New England Journal of Medicine, vol.359, issue.25, pp.2685-92, 2008.
DOI : 10.1056/NEJMoa0806277

F. Lorenzo, C. Yang, N. Tang-fui, M. Vankayalapati, H. Zhuang et al., A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma, Journal of Molecular Medicine, vol.359, issue.4, pp.507-519, 2013.
DOI : 10.1007/s00109-012-0967-z

C. Ladroue, D. Hoogewijs, S. Gad, R. Carcenac, F. Storti et al., Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia, Haematologica, vol.97, issue.1, pp.9-14, 2012.
DOI : 10.3324/haematol.2011.044644
URL : https://hal.archives-ouvertes.fr/inserm-01401555

A. Ginouves, K. Ilc, N. Macias, J. Pouyssegur, and E. Berra, PHDs overactivation during chronic hypoxia "desensitizes" HIF?? and protects cells from necrosis, Proceedings of the National Academy of Sciences, vol.105, issue.12, pp.4745-50, 2008.
DOI : 10.1073/pnas.0705680105
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2290777